$FATE
FATE THERAPEUTICS INC

2016 Q1 Form 10-K Financial Statement

#000156459016013981 Filed on March 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 2014 Q4
Revenue $1.322M $2.431M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.600M $10.35M $2.080M
YoY Change -5.8% 22.2% 11.23%
% of Gross Profit
Research & Development $6.636M $19.86M $3.870M
YoY Change 45.27% 20.81% 27.72%
% of Gross Profit
Depreciation & Amortization $227.0K $687.0K $130.0K
YoY Change 77.34% 38.51% 0.0%
% of Gross Profit
Operating Expenses $9.238M $30.21M $5.943M
YoY Change 26.13% 21.32% 21.24%
Operating Profit -$7.916M -$27.78M
YoY Change 8.08% 11.56%
Interest Expense $488.0K $2.220M -$290.0K
YoY Change -12.54% 304.37% -65.48%
% of Operating Profit
Other Income/Expense, Net -$461.0K -$2.210M
YoY Change -17.24% 125.74%
Pretax Income -$8.380M -$29.99M -$6.230M
YoY Change 6.35% 15.88% 8.54%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$8.377M -$29.99M -$6.233M
YoY Change 6.29% 15.88% 8.61%
Net Earnings / Revenue -633.66% -1233.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$291.2K -$1.177M -$303.9K
COMMON SHARES
Basic Shares Outstanding 28.86M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.60M $64.80M $49.10M
YoY Change 31.44% 31.98% -9.07%
Cash & Equivalents $39.49M $64.80M $49.10M
Short-Term Investments $16.10M
Other Short-Term Assets $1.000M $800.0K $800.0K
YoY Change 150.0% 0.0% 33.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $56.60M $65.70M $49.86M
YoY Change 32.24% 31.66% -8.76%
LONG-TERM ASSETS
Property, Plant & Equipment $2.000M $2.200M $1.200M
YoY Change 33.33% 83.33% 48.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K $100.0K
YoY Change -50.0% 0.0% 0.0%
Total Long-Term Assets $2.100M $2.300M $1.339M
YoY Change 23.53% 76.92% 43.67%
TOTAL ASSETS
Total Short-Term Assets $56.60M $65.70M $49.86M
Total Long-Term Assets $2.100M $2.300M $1.339M
Total Assets $58.70M $68.00M $51.20M
YoY Change 31.91% 32.81% -7.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.000M $1.000M $600.0K
YoY Change 53.85% 66.67% -12.02%
Accrued Expenses $2.000M $2.400M $2.300M
YoY Change 11.11% 4.35% 12.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.700M $7.600M $1.500M
YoY Change 133.33% 406.67% -13.39%
Total Short-Term Liabilities $13.90M $13.40M $4.600M
YoY Change 117.19% 191.3% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $8.700M $10.70M $18.10M
YoY Change -46.95% -40.88%
Other Long-Term Liabilities $5.400M $5.800M $200.0K
YoY Change 1250.0% 2800.0% 100.0%
Total Long-Term Liabilities $14.10M $16.50M $18.30M
YoY Change -16.07% -9.84% 18200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.90M $13.40M $4.600M
Total Long-Term Liabilities $14.10M $16.50M $18.30M
Total Liabilities $28.00M $29.90M $22.80M
YoY Change 20.69% 31.14% 385.11%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.70M $38.00M $28.34M
YoY Change
Total Liabilities & Shareholders Equity $58.70M $68.00M $51.20M
YoY Change 31.91% 32.81% -7.89%

Cashflow Statement

Concept 2016 Q1 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$8.377M -$29.99M -$6.233M
YoY Change 6.29% 15.88% 8.61%
Depreciation, Depletion And Amortization $227.0K $687.0K $130.0K
YoY Change 77.34% 38.51% 0.0%
Cash From Operating Activities -$7.250M -$18.40M -$6.150M
YoY Change 13.64% -17.93% 34.57%
INVESTING ACTIVITIES
Capital Expenditures $178.0K $1.498M -$270.0K
YoY Change -60.62% 69.84% 80.0%
Acquisitions
YoY Change
Other Investing Activities -$16.17M $0.00 $0.00
YoY Change
Cash From Investing Activities -$16.34M -$1.500M -$270.0K
YoY Change 3531.11% 70.45% 80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.580M
YoY Change
Debt Paid & Issued, Net $1.873M $1.546M
YoY Change -11.66%
Cash From Financing Activities -1.730M 35.60M 10.00M
YoY Change -2262.5% 93.79% -74.8%
NET CHANGE
Cash From Operating Activities -7.250M -18.40M -6.150M
Cash From Investing Activities -16.34M -1.500M -270.0K
Cash From Financing Activities -1.730M 35.60M 10.00M
Net Change In Cash -25.32M 15.70M 3.580M
YoY Change 275.11% -418.46% -89.76%
FREE CASH FLOW
Cash From Operating Activities -$7.250M -$18.40M -$6.150M
Capital Expenditures $178.0K $1.498M -$270.0K
Free Cash Flow -$7.428M -$19.90M -$5.880M
YoY Change 8.72% -14.61% 33.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49101000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64809000
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
166230000
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28861711
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015Q4 fate Repurchase Liability For Unvested Equity Awards Current
RepurchaseLiabilityForUnvestedEquityAwardsCurrent
1000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
971000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
180393000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
345000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
2431000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-17675000
CY2015 us-gaap Contracts Revenue
ContractsRevenue
2431000
CY2013 us-gaap Contracts Revenue
ContractsRevenue
626000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19861000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
29000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
49861000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10688000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1200000
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
799000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
760000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2210000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.27
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25484262
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20451840
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.18
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54036000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9087000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10352000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8469000
CY2015 us-gaap Operating Expenses
OperatingExpenses
30213000
CY2014 us-gaap Operating Expenses
OperatingExpenses
24904000
CY2013 us-gaap Operating Expenses
OperatingExpenses
18646000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-27782000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-24904000
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2015 us-gaap Interest Expense
InterestExpense
2220000
CY2014 us-gaap Interest Expense
InterestExpense
549000
CY2013 us-gaap Interest Expense
InterestExpense
796000
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-432000
CY2013 us-gaap Fair Value Instruments Classified In Shareholders Equity Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-2421000
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
8000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-979000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3219000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-29992000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-25883000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-20894000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.54
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5896171
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-52825000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2013 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
49000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1554000
CY2013 fate Stock Issued During Period Value Technology
StockIssuedDuringPeriodValueTechnology
13000
CY2013 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
336000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40480000
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
56526000
CY2013 fate Stock Issued During Period Value Conversion Of Convertible Notes Into Common Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesIntoCommonStock
22076000
CY2013 fate Stock Issued During Period Value Exchange Of Exchangeable Shares Into Common Stock
StockIssuedDuringPeriodValueExchangeOfExchangeableSharesIntoCommonStock
3318000
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
192000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
50848000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
142000
CY2014 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
49000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2434000
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
375000
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
375000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
420000
CY2015 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
44000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2400000
CY2015 fate Incentive Bonuses Paid In Value
IncentiveBonusesPaidInValue
97000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32149000
CY2015 fate Common Stock Issued Value To Collaborative Partner
CommonStockIssuedValueToCollaborativePartner
4580000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
687000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
496000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
571000
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2400000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2434000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1554000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
176000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
24000
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
394000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
651000
CY2014 us-gaap Paid In Kind Interest
PaidInKindInterest
167000
CY2013 us-gaap Paid In Kind Interest
PaidInKindInterest
147000
CY2015 us-gaap Straight Line Rent
StraightLineRent
24000
CY2014 us-gaap Straight Line Rent
StraightLineRent
52000
CY2013 us-gaap Straight Line Rent
StraightLineRent
195000
CY2015 fate Deferred Revenue Expense
DeferredRevenueExpense
-7335000
CY2013 fate Deferred Revenue Expense
DeferredRevenueExpense
63000
CY2014 fate Stock Based Milestone Charges And Change In Fair Value Of Exchangeable Shares
StockBasedMilestoneChargesAndChangeInFairValueOfExchangeableShares
375000
CY2013 fate Stock Based Milestone Charges And Change In Fair Value Of Exchangeable Shares
StockBasedMilestoneChargesAndChangeInFairValueOfExchangeableShares
2767000
CY2013 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
CY2014 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
3000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
146000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1271000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
477000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
163000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1578000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18397000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22419000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15373000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1498000
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1763065
CY2013Q4 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
480763
CY2015 fate Adjustment To Additional Paid In Capital Reclassification Of Exchangeable Shares
AdjustmentToAdditionalPaidInCapitalReclassificationOfExchangeableShares
3300000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
882000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
244000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1498000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-882000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-238000
CY2015 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
420000
CY2014 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
142000
CY2013 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
23000
CY2015 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
32149000
CY2013 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
40480000
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
23736000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4580000
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1546000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1750000
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1679000
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
26000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
35603000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18366000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
60560000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15708000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4935000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
44949000
CY2015 us-gaap Interest Paid
InterestPaid
1353000
CY2014 us-gaap Interest Paid
InterestPaid
494000
CY2013 us-gaap Interest Paid
InterestPaid
250000
CY2014 fate Issuance Of Warrants In Connection With Long Term Debt
IssuanceOfWarrantsInConnectionWithLongTermDebt
375000
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
56526000
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
22076000
CY2013 fate Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
192000
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company&#8217;s consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;). The preparation of the Company&#8217;s consolidated financial statements requires it to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accrued expenses. Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</p></div>
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash and cash equivalents. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held.</p></div>
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2015Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2015Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2015Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2015 us-gaap Revenue Recognition Milestone Method Factors
RevenueRecognitionMilestoneMethodFactors
(i) persuasive evidence that an agreement exists; (ii) delivery of the products and/or services has occurred; (iii) the selling price is fixed or determinable; and (iv) collectability is reasonably assured.
CY2015 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
more than 50 percent
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2721587
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2560082
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8757000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
4055000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
21569000
CY2015Q4 fate Long Term Debt Maturities Repayments Interest Included In Payments
LongTermDebtMaturitiesRepaymentsInterestIncludedInPayments
1615000
CY2015Q4 fate Long Term Debt Maturities Additional Payments Due On Maturity
LongTermDebtMaturitiesAdditionalPaymentsDueOnMaturity
1500000
CY2015Q4 fate Unamortized Debt Discounts And Debt Issuance Cost
UnamortizedDebtDiscountsAndDebtIssuanceCost
216000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1270000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1088000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2358000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5632000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3987000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3472000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2787000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
993000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1234000
CY2015Q4 fate Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
446000
CY2014Q4 fate Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
415000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1000000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
611000
CY2015 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
19956
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18454000
CY2014Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20000000
CY2015Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
77000
CY2014Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
381000
CY2015Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
18377000
CY2014Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
19619000
CY2015Q4 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
7689000
CY2014Q4 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
1546000
CY2015Q4 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
139000
CY2014Q4 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
11000
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
2200000
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
500000
CY2015Q1 fate Operating Lease Extended Term
OperatingLeaseExtendedTerm
P15M
CY2015Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
100000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1200000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
900000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
900000
CY2015 fate Minimum Annual Payments To Maintain Licenses
MinimumAnnualPaymentsToMaintainLicenses
300000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8757000
CY2015Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
10027000
CY2015Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
9845000
CY2015Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
4055000
CY2015Q4 us-gaap Contractual Obligation
ContractualObligation
23927000
CY2013Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
68360186
CY2013Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
44967690
CY2013Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
7229590
CY2015 us-gaap Dividends
Dividends
0
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2434000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1554000
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4358875
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4653943
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10198000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8800000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-256000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7104000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2226000
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1311000
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1011000
CY2015 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
43000
CY2014 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
159000
CY2013 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
755000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
213000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
426000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
161000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
295000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1329000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
491000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1820000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
374000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2624000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1076000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
7988000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-7446000
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
6937000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
6040000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
594000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
596000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
373000
CY2015 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
1733000
CY2015 fate Income Tax Reconciliation Tax Attribute Limitation
IncomeTaxReconciliationTaxAttributeLimitation
2727000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
949000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3869000
CY2015Q4 fate Unrecognized Tax Benefits Resulting In Net Operating Loss And Tax Credit Carryforward
UnrecognizedTaxBenefitsResultingInNetOperatingLossAndTaxCreditCarryforward
0
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-37000
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0
CY2009Q1 fate Defined Contribution Plan Minimum Age Of Employee
DefinedContributionPlanMinimumAgeOfEmployee
P21Y
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-8000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3887000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10378000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7580000
CY2015Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
13042000
CY2014Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
13905000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28963000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25620000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1274000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2221000
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
921000
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1050000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2494000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
950000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
961000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47644000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43757000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47644000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43757000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1034000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
5984000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
5943000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6980000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-6067000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-6603000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-6233000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30

Files In Submission

Name View Source Status
0001564590-16-013981-index-headers.html Edgar Link pending
0001564590-16-013981-index.html Edgar Link pending
0001564590-16-013981.txt Edgar Link pending
0001564590-16-013981-xbrl.zip Edgar Link pending
fate-10k_20151231.htm Edgar Link pending
fate-20151231.xml Edgar Link completed
fate-20151231.xsd Edgar Link pending
fate-20151231_cal.xml Edgar Link unprocessable
fate-20151231_def.xml Edgar Link unprocessable
fate-20151231_lab.xml Edgar Link unprocessable
fate-20151231_pre.xml Edgar Link unprocessable
fate-ex1015_610.htm Edgar Link pending
fate-ex1016_611.htm Edgar Link pending
fate-ex1017_612.htm Edgar Link pending
fate-ex105_609.htm Edgar Link pending
fate-ex231_11.htm Edgar Link pending
fate-ex311_12.htm Edgar Link pending
fate-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201603031736066433600.jpg Edgar Link pending
g201603031736069403600.jpg Edgar Link pending
g201603031736071284411.jpg Edgar Link pending
g201603031736071434412.jpg Edgar Link pending
g201603031736071594413.jpg Edgar Link pending
g201603031736081974706.jpg Edgar Link pending
g201603031736096194706.jpg Edgar Link pending
g201603031736096344707.jpg Edgar Link pending
g201603031736096664708.jpg Edgar Link pending
g201603031736239594589.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending